Therapeutic Asset Ratings

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Propofol Cancer	Hong Kong Children's Hospital	P4	BB (69)
Propofol Gastric Ulcer	RenJi Hospital	P4	BB (69)
Propofol Gastrointestinal Polyp	RenJi Hospital	P4	BB (69)
Propofol Cardiovascular Disorder	Helse Fonna	P4	BB (69)
Propofol Delirium	RenJi Hospital	P4	BB (69)
Quadrivalent Inactivated Influenza Vaccine Relapsing-Remitting Multiple Sclerosis	Novartis Pharmaceuticals	P4	BB (69)
Quetiapine Major Depressive Disorder	Dr. Inge Winter	P4	BB (69)
Ramifentanyl Chronic Pain Syndrome	Beijing Tiantan Hospital	P4	BB (69)
Remimazolam Osteoarthritis, Hip	Seoul National University Hospital	P4	BB (69)
Remimazolam Osteoarthritis, Knee	Seoul National University Hospital	P4	BB (69)
Remimazolam Bipolar Disorder	Yeongseok Yun	P4	BB (69)
Remimazolam Major Depressive Disorder	Yeongseok Yun	P4	BB (69)
Remimazolam Schizophrenia	Yeongseok Yun	P4	BB (69)
Retigabine Epilepsy	Xenon Pharmaceuticals Inc.	P4	BB (69)
Riluzole Amyotrophic Lateral Sclerosis	AB Science	P4	BB (69)
Rimegepant Migraine With Aura	University of South Florida	P4	BB (69)
Rimegepant Migraine Without Aura	University of South Florida	P4	BB (69)
Rimegepant Hyperacusis	Pfizer	P4	BB (69)
Rimegepant Photosensitivity Disease	Pfizer	P4	BB (69)
Rituximab Primary Central Nervous System Lymphoma	Ono Pharmaceutical Co., Ltd.	P4	BB (69)
Rocuronium Ion Neuromuscular Junction Disease	Merck Sharp & Dohme LLC	P4	BB (69)
Romidepsin Myeloproliferative Neoplasm	Sawa Ito, MD	P4	BB (69)
Romidepsin Myelodysplastic Syndrome	Sawa Ito, MD	P4	BB (69)
Selenium Chronic Prostatitis	Clinica Urologica Molinette - Città della Saliute e della Scienza	P4	BB (69)
Semaglutide Pseudotumor Cerebri	Rigmor Højland Jensen	P4	BB (69)

Showing 1801 to 1825 of 42,327 assets

PreviousPage 73 of 1694Next